Simplex Trading
CLSD

Simplex Trading’s Clearside Biomedical CLSD Stock Holding History

Simplex Trading’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-273
Closed -$3K – 8758
2025
Q1 		$3K Sell
273
-707
-72% -$10.2K ﹤0.01% 7789
2024
Q4 		$13K Buy
980
+7
+0.7% +$115 ﹤0.01% 6992
2024
Q3 		$18K Buy
+973
New +$16.6K ﹤0.01% 6735
2024
Q1 		– Sell
-1,947
Closed -$34K – 8936
2023
Q4 		$34K Sell
1,947
-53
-3% -$756 ﹤0.01% 6448
2023
Q3 		$26K Sell
2,000
-60
-3% -$909 ﹤0.01% 6379
2023
Q2 		$34K Sell
2,060
-233
-10% -$4.01K ﹤0.01% 6209
2023
Q1 		$35K Sell
2,293
-1,094
-32% -$21.2K ﹤0.01% 6318
2022
Q4 		$56K Buy
3,387
+1,054
+45% +$19K ﹤0.01% 5723
2022
Q3 		$39K Buy
2,333
+1,273
+120% +$27.9K ﹤0.01% 6760
2022
Q2 		$23K Sell
1,060
-620
-37% -$15.1K ﹤0.01% 7434
2022
Q1 		$57K Buy
1,680
+1,420
+546% +$42.5K ﹤0.01% 6954
2021
Q4 		$10K Sell
260
-3,820
-94% -$247K ﹤0.01% 9004
2021
Q3 		$295K Hold
4,080
– – ﹤0.01% 4928
2021
Q2 		$298K Buy
4,080
+4,060
+20,300% +$189K ﹤0.01% 4998
2021
Q1 		$72K Buy
+20
New +$1K ﹤0.01% 6169
2020
Q3 		– Sell
-1
Closed -$3K – 7846
2020
Q2 		$3K Sell
1
-2
-67% -$59 ﹤0.01% 7129
2020
Q1 		$6K Buy
3
+2
+200% +$74 ﹤0.01% 6735
2019
Q4 		$3K Buy
+1
New +$21 ﹤0.01% 6865
2019
Q3 		– Sell
-9
Closed -$13K – 7294
2019
Q2 		$13K Buy
9
+6
+200% +$107 ﹤0.01% 5935
2019
Q1 		$6K Sell
3
-2
-40% -$40 ﹤0.01% 6397
2018
Q4 		$8K Buy
+5
New +$235 ﹤0.01% 5960
2018
Q3 		– Sell
-3
Closed -$50K – 7458
2018
Q2 		$50K Buy
3
+1
+50% +$169 ﹤0.01% 5057
2018
Q1 		$5K Buy
+2
New +$244 ﹤0.01% 4611

Other funds holding CLSD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $6.15B AUM 22.62% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Simplex Trading's CLSD Position: Q3 2025 in Review

Simplex Trading sold out of Clearside Biomedical (CLSD) in Q3 2025, closing a stake of 8 shares.

Simplex Trading first reported a position in CLSD in Q2 2018 and held it in 20 quarters. The position peaked at $308K in Q2 2018. 26 funds tracked by Wall St. Rank hold CLSD as of Q3 2025.

  • Simplex Trading reported no remaining Clearside Biomedical position as of Q3 2025 after selling out during the quarter.
  • Simplex Trading sold 8 Clearside Biomedical shares in Q3 2025.
  • Simplex Trading first reported a position in Clearside Biomedical in Q2 2018 and held it in 20 quarters.
  • Simplex Trading's Clearside Biomedical position peaked at $308K in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2025.

Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.